Rotavirus Vaccine Global Market Report 2025

Global Rotavirus Vaccine Market Report 2025

Rotavirus Vaccine Global Market Report 2025 – By Type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types), By Application (Adult, Pediatric), By End Users (Hospitals, Clinics, Academic Research) – Market Size, Trends, And Global Forecast 2025-2034

Name: Rotavirus Vaccine Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Rotavirus Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Rotavirus Vaccine Global Market Report 2025

Proud Members Of

What Is Covered Under Rotavirus Vaccine Market?

The rotavirus vaccine refers to a vaccine designed to protect against rotavirus infections, which are a common cause of severe diarrhea and gastroenteritis in infants and young children. This vaccine is administered orally and contains live attenuated or inactivated strains of the rotavirus to stimulate an immune response and provide immunity against the virus.

The main types of rotavirus vaccine include rotarix, rotateq, rotavac, rotavin-M1, lanzhou lamb, and others. Rotarix is a live attenuated oral rotavirus vaccine designed to protect infants from rotavirus gastroenteritis, which can cause severe diarrhea and dehydration. The application are categorized into Adult and Pediatric for end users including hospitals, clinics, and academic research.

What Is The Rotavirus Vaccine Market Size 2025 And Growth Rate?

The rotavirus vaccine market size has grown rapidly in recent years. It will grow from $9.18 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased awareness of rotavirus, improved healthcare infrastructure, government immunization programs, rising incidence of rotavirus infections, rising birth rates.

What Is The Rotavirus Vaccine Market Growth Forecast?

The rotavirus vaccine market size is expected to see rapid growth in the next few years. It will grow to $14.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising birth rates, the expansion of vaccination programs, an increased focus on preventive healthcare, economic growth and improved access, and government policies and funding. Major trends in the forecast period include advancements in vaccine technology, advancements in oral-dosing technologies, improved vaccine formulations, combination vaccines, and digital health integration.

Rotavirus Vaccine Market Size and growth rate 2025 to 2029: Graph

How Is The Rotavirus Vaccine Market Segmented?

The rotavirus vaccine market covered in this report is segmented –

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

Subsegments:

1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics

2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics

3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics

4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics

5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics

6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines

Book your 30 minutes free consultation with our research experts

What Is Driving The Rotavirus Vaccine Market? Impact Of Rising Birth Rates On Rotavirus Vaccine Market Growth

The rising birth rates are expected to propel the growth of the rotavirus vaccine market going forward. Birth rates refer to the number of live births per 1,000 people in a population over a specific period, typically expressed annually. Birth rates are influenced by higher economic stability and growth, as well as supportive policies such as parental leave, child benefits, and childcare subsidies. The use of rotavirus vaccines helps to reduce the incidence of severe rotavirus gastroenteritis in infants, thereby improving child health outcomes and reducing healthcare costs associated with rotavirus infections. For instance, in January 2023, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health organization, the United States witnessed a 1% increase in registered births, totaling 3,664,292, compared to the previous year. Therefore, rising birth rates will drive the growth of the rotavirus vaccine market.

Who Are The Major Players In The Global Rotavirus Vaccine Market?

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd., Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

What Are The Key Trends Of The Global Rotavirus Vaccine Market? Oral-Dosing Applicators Enhance Rotavirus Vaccine Delivery And Compliance

Major companies operating in the rotavirus vaccine market are adopting oral-dosing applicators to enhance vaccine delivery efficiency and improve patient compliance. Oral-dosing applicators are medical devices designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For instance, in November 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, received U.S. Food and Drug Administration (FDA) approval for a new oral-dosing applicator-only formulation of ROTARIX (Rotavirus Vaccine, Live, Oral). This liquid formulation prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants. The new presentation simplifies vaccine preparation for healthcare providers by eliminating the need for dose reconstitution at the point of use.

What Are Latest Mergers And Acquisitions In The Rotavirus Vaccine Market? MCRI And Incepta Pharmaceuticals Join Forces To Improve Access To Rotavirus Vaccines

In June 2024, Murdoch Children's Research Institute, an Australia-based child health research institute, partnered with Incepta Pharmaceuticals Limited. The collaboration between MCRI and Incepta Pharmaceuticals is designed to advance the protection of children against rotavirus by developing and distributing effective vaccines. This partnership is dedicated to expanding access to critical rotavirus vaccines, targeting regions with high infection rates and limited healthcare resources. Incepta Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company that is developing rotavirus vaccines.

What Is The Regional Outlook For The Global Rotavirus Vaccine Market?

North America was the largest region in the rotavirus vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rotavirus vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rotavirus Vaccine Market?

The rotavirus vaccine market consists of sales of combination vaccines, vaccine delivery systems, vaccine doses, and packs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rotavirus Vaccine Industry?

The rotavirus vaccine market research report is one of a series of new reports from the business research company that provides rotavirus vaccine market statistics, including rotavirus vaccine industry global market size, regional shares, competitors with an rotavirus vaccine market share, detailed rotavirus vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the rotavirus vaccine industry. This rotavirus vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rotavirus Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	10.14 billion
Revenue Forecast In 2034	$14.96 billion
Growth Rate	CAGR of 10.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The rotavirus vaccine market covered in this report is segmented – 1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types 2) By Application: Adult, Pediatric 3) By End Users: Hospitals, Clinics, Academic Research Subsegments: 1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics 2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics 3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics 4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics 5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics 6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd., Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Rotavirus Vaccine Market Characteristics

3. Rotavirus Vaccine Market Trends And Strategies

4. Rotavirus Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Rotavirus Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Rotavirus Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Rotavirus Vaccine Market Growth Rate Analysis

5.4. Global Rotavirus Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Rotavirus Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Rotavirus Vaccine Total Addressable Market (TAM)

6. Rotavirus Vaccine Market Segmentation

6.1. Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Other Types

6.2. Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Pediatric

6.3. Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Academic Research

6.4. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion